Kidney Health & Function Support Protocol
Primary Stack
Core supplements with strongest evidenceMay reduce inflammation and proteinuria; supports cardiovascular health in CKD patients
Antioxidant and anti-inflammatory that may protect kidney function and reduce oxidative stress
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsDeficiency very common in CKD; supplementation important but requires monitoring
Supporting Studies (1)
Antioxidant that may reduce oxidative stress and support mitochondrial function in kidney cells
Supporting Studies (1)
May reduce uremic toxins by modulating gut microbiome in CKD patients
Supporting Studies (1)
Corrects metabolic acidosis in CKD; may slow disease progression
Supporting Studies (1)
Antioxidant that may protect kidneys from oxidative damage, especially in diabetic nephropathy
Supporting Studies (1)
Glutathione precursor that may protect against contrast-induced nephropathy and oxidative stress
Supporting Studies (1)
Addresses elevated homocysteine common in CKD; supports overall metabolism
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Kidney health is crucial as the kidneys filter waste, balance fluids, regulate blood pressure, produce hormones, and maintain mineral balance. Chronic kidney disease (CKD) affects about 15% of adults and can progress silently to kidney failure. Risk factors include diabetes, high blood pressure, heart disease, and family history. While preventing progression requires managing underlying conditions, certain supplements may support kidney function and address complications.
CRITICAL: CKD requires nephrology care. Many supplements need dose adjustment or are contraindicated in kidney disease. Avoid high-dose vitamin A, potassium supplements, and excessive protein without guidance. Some herbal supplements can be nephrotoxic. ALWAYS discuss supplements with your nephrologist before taking them.
* Omega-3 Fatty Acids may help reduce inflammation and proteinuria (protein in urine) in kidney disease. They also support cardiovascular health, which is especially important since heart disease is the leading cause of death in CKD patients.
* Resveratrol has antioxidant and anti-inflammatory properties that may protect kidney cells from damage. Research suggests it may help preserve kidney function, particularly in the context of diabetes-related kidney disease.
* Vitamin D deficiency is extremely common in CKD because the kidneys normally activate vitamin D. Low vitamin D contributes to bone disease, muscle weakness, and cardiovascular risk. Supplementation is often necessary but requires monitoring, and advanced CKD may require active vitamin D (calcitriol or analogs).
* CoQ10 supports mitochondrial energy production and has antioxidant effects. It may help reduce oxidative stress that contributes to kidney damage.
* Probiotics are increasingly recognized as beneficial in CKD. The gut microbiome is altered in kidney disease, producing uremic toxins. Probiotics may reduce these toxins and improve symptoms.
* Sodium Bicarbonate helps correct metabolic acidosis, a common complication of CKD that can accelerate disease progression and worsen bone and muscle health.
* Alpha-Lipoic Acid may help protect against diabetic nephropathy through its antioxidant effects.
* NAC provides cysteine to make glutathione, the body's major antioxidant. It may help protect kidneys from contrast dye damage and oxidative stress.
* B Vitamins help address elevated homocysteine levels common in CKD and support overall metabolism. CKD patients often need supplementation, but water-soluble vitamins are lost during dialysis.
Expected timeline: These supplements provide ongoing support. Effects on kidney function parameters may take months to assess. Vitamin D: check levels in 8-12 weeks. Acidosis correction: monitor bicarbonate levels. Work closely with your nephrologist for monitoring.
Clinical Perspective
Chronic kidney disease (CKD): defined by GFR <60 mL/min/1.73m2 or markers of kidney damage for >3 months. Staging: G1-G5 based on GFR; A1-A3 based on albuminuria. Leading causes: diabetes (40%), hypertension (25%), glomerulonephritis. Complications: anemia, bone mineral disorders, metabolic acidosis, hyperkalemia, cardiovascular disease, uremic symptoms. Progression risk: higher albuminuria, lower GFR, uncontrolled diabetes/HTN.
CRITICAL: Nephrology referral for GFR <30, rapid decline, significant proteinuria. Many supplements require dose adjustment or are contraindicated in CKD. Avoid: high-dose vitamin A (accumulates), potassium supplements (hyperkalemia risk), high-dose vitamin C (oxalate stones), phosphorus-containing supplements, certain herbals (aristolochic acid, chromium, creatine). Protein restriction controversial - adequate protein important, especially in dialysis. Monitor potassium, phosphorus, calcium with any intervention.
* Omega-3 Fatty Acids (B-grade): Anti-inflammatory; may reduce proteinuria, support cardiovascular health. Cochrane review: omega-3s may reduce triglycerides, uncertain effect on kidney function (PMID: 29699989). Meta-analysis: may slow eGFR decline (PMID: 28389043). 2-4g EPA+DHA daily. Generally safe in CKD.
* Resveratrol (B-grade): Activates SIRT1, reduces oxidative stress, anti-inflammatory. Systematic review: nephroprotective effects in preclinical and clinical studies (PMID: 28983199). 100-500mg daily. Limited long-term human data in CKD.
* Vitamin D (B-grade): CKD impairs 1-alpha hydroxylation; deficiency near-universal in advanced CKD. Causes: renal osteodystrophy, secondary hyperparathyroidism, cardiovascular disease. Systematic review: supplementation needed but optimal approach varies by CKD stage (PMID: 28395770). Stages 1-3: cholecalciferol 1000-2000 IU daily if deficient. Stages 4-5: active vitamin D (calcitriol, paricalcitol) often needed - per nephrologist. Monitor calcium, phosphorus, PTH.
* CoQ10 (C-grade): Antioxidant; may reduce oxidative stress in CKD. Systematic review: may improve some metabolic parameters but limited CKD-specific data (PMID: 29145993). 100-200mg daily. No dose adjustment needed.
* Probiotics (B-grade): Gut-kidney axis: altered microbiome in CKD increases uremic toxins (indoxyl sulfate, p-cresol). Meta-analysis: probiotics reduce uremic toxins and may improve GFR (PMID: 30218621). 10-20 billion CFU daily. Safe in CKD.
* Sodium Bicarbonate (B-grade): Corrects metabolic acidosis (serum bicarbonate <22 mEq/L common in CKD). Acidosis accelerates progression, worsens bone/muscle. Meta-analysis: bicarbonate supplementation may slow CKD progression (PMID: 30500122). Target bicarbonate >22 mEq/L. Start 650-1300mg BID-TID. Monitor sodium load, BP.
* Alpha-Lipoic Acid (C-grade): Antioxidant; studied in diabetic nephropathy. Review: may reduce proteinuria and oxidative stress (PMID: 24571521). 300-600mg daily. No dose adjustment needed.
* NAC (C-grade): Glutathione precursor. Cochrane review: NAC may not prevent contrast-induced nephropathy (PMID: 28864311). May have other antioxidant benefits. 600-1200mg daily. Studies mixed.
* B Vitamins (C-grade): Elevated homocysteine common in CKD. Review: B vitamins lower homocysteine but don't clearly improve outcomes (PMID: 20194231). Water-soluble vitamins lost in dialysis - supplementation needed. Avoid high-dose B6 (neuropathy).
Biomarker targets: eGFR (stability or slowed decline), UACR (urine albumin-to-creatinine ratio), blood pressure (<130/80), HbA1c (if diabetic), bicarbonate (>22 mEq/L), potassium, phosphorus, calcium, PTH, 25(OH)D.
Protocol notes: First priority: control diabetes and blood pressure (ACEi/ARBs preferred if proteinuria). Dietary modifications: moderate protein (0.8-1.0 g/kg non-dialysis), low sodium (<2g/day), potassium and phosphorus restriction in advanced CKD. Avoid NSAIDs (nephrotoxic). Hydration important but avoid overhydration in advanced CKD. Manage anemia (EPO, IV iron). Prevent contrast nephropathy (hydration, consider contrast alternatives). Avoid nephrotoxins (aminoglycosides, certain supplements). Vaccinations (hepatitis B, pneumococcal). Dialysis/transplant planning for progressive disease. Statins for cardiovascular protection (high risk in CKD). Monitor and treat hyperparathyroidism. Depression screening. Palliative care discussion for advanced disease.